≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Carcinoma in situ, eye (controls excluding all cancers)

PheWeb

CD2_INSITU_EYE_EXALLC

No definition available.

Endpoint definition

↥
FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector
diagram bullet

Check conditions

not C3_EYE_ADNEXA

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D09.2&
Hospital discharge: ICD-9 2340
Cause of death: ICD-10 D09.2&
Cause of death: ICD-9 2340
Cancer registry: Topography ICD-O-3 C69
Cancer registry: Morphology ICD-O-3 ANY
Cancer registry: Behaviour codes 2

3 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

7

diagram downward connector
CD2_INSITU_EYE_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF9
Parent code in ICD-10 D09

Not enough data for upset plot.

Not enough data for upset table.

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 7 - 6
Unadjusted prevalence (%) 0.00 - 0.00
Mean age at first event (years) 64.02 - 65.06

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_INSITU_EYE_EXALLC – Carcinoma in situ, eye (controls excluding all cancers)
GWS hits:

Survival analyses between endpoints

↥

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Carcinoma in situ, eye (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.